Sedative, hypnotic or anxiolytic abuse, uncomplicated
ICD-10 F13.10 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic abuse, uncomplicated.
F13.10 refers to the abuse of sedative, hypnotic, or anxiolytic substances without the presence of complications. This condition is characterized by a pattern of use that leads to significant impairment or distress, including a strong desire to consume these substances, unsuccessful attempts to cut down or control use, and continued use despite adverse consequences. Patients may experience tolerance, where increasing amounts are needed to achieve the desired effect, and withdrawal symptoms upon cessation. Common substances in this category include benzodiazepines and barbiturates. The diagnosis is made based on clinical assessment, including patient history and behavioral observations. Treatment typically involves behavioral therapies, counseling, and support groups, with a focus on addressing underlying psychological issues and promoting recovery. It is crucial for healthcare providers to monitor patients for signs of withdrawal or overdose, as these can lead to serious health complications.
Detailed patient history, including substance use patterns and mental health evaluations.
Patients presenting with anxiety or insomnia who misuse sedatives.
Consideration of comorbid psychiatric disorders and the need for integrated treatment approaches.
Comprehensive assessment of substance use, including frequency, quantity, and impact on life.
Patients seeking help for substance abuse with a focus on sedatives.
Focus on harm reduction strategies and potential for withdrawal management.
Used when assessing a patient for sedative abuse.
Detailed notes on patient history and assessment findings.
Psychiatry and addiction medicine should document the assessment thoroughly.
F13.10 refers to uncomplicated abuse of sedatives, while F13.20 indicates dependence, which includes withdrawal symptoms and a more severe pattern of use.
